| Miss Shelley Suzanne Noland, MD | |
|
13400 E Shea Blvd, Scottsdale, AZ 85259-5452 | |
| (480) 301-8000 | |
| Not Available |
| Full Name | Miss Shelley Suzanne Noland |
|---|---|
| Gender | Female |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 18 Years |
| Location | 13400 E Shea Blvd, Scottsdale, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053592139 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 50995 (Arizona) | Secondary |
| 208200000X | Plastic Surgery | 50995 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Hospital | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic - Arizona | 7012829930 | 1395 |
News Archive
Pfizer Inc. announced that it has settled its litigation against Mylan Inc. and Mylan Pharmaceuticals Inc. relating to Pfizer's patents covering Detrol LA (tolterodine tartrate) extended-release capsules.
Using clinical data collected over the past decade through a U.S. cancer registry, researchers at the University of California, San Diego School of Medicine demonstrated that significant strides have been made in improving the survival of adult patients with low-grade gliomas, a slow-growing yet deadly form of primary brain cancer.
The project, funded by the Ministry of Health, aims to ascertain whether timber workers exposed to the PCPs (pentachlorophenols) are dying earlier, getting cancers more often and suffering more chronic health problems, including fatigue, nausea and neuropsychological dysfunction.
The coronavirus pandemic (COVID-19) has swept across the globe, infecting more than 18 million people. With the rapid spread of the virus, the World Health Organization (WHO) warns that there might never be a "silver bullet" to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Novartis Pharmaceuticals Corporation announced today that a Phase III study of Afinitor (everolimus) tablets plus best supportive care met its primary endpoint, showing the drug significantly extended progression-free survival, or time without tumor growth, in patients with advanced pancreatic neuroendocrine tumors.
› Verified 3 days ago
| Entity Name | Mayo Clinic Arizona |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558332494 PECOS PAC ID: 7012829930 Enrollment ID: O20031105000782 |
News Archive
Pfizer Inc. announced that it has settled its litigation against Mylan Inc. and Mylan Pharmaceuticals Inc. relating to Pfizer's patents covering Detrol LA (tolterodine tartrate) extended-release capsules.
Using clinical data collected over the past decade through a U.S. cancer registry, researchers at the University of California, San Diego School of Medicine demonstrated that significant strides have been made in improving the survival of adult patients with low-grade gliomas, a slow-growing yet deadly form of primary brain cancer.
The project, funded by the Ministry of Health, aims to ascertain whether timber workers exposed to the PCPs (pentachlorophenols) are dying earlier, getting cancers more often and suffering more chronic health problems, including fatigue, nausea and neuropsychological dysfunction.
The coronavirus pandemic (COVID-19) has swept across the globe, infecting more than 18 million people. With the rapid spread of the virus, the World Health Organization (WHO) warns that there might never be a "silver bullet" to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Novartis Pharmaceuticals Corporation announced today that a Phase III study of Afinitor (everolimus) tablets plus best supportive care met its primary endpoint, showing the drug significantly extended progression-free survival, or time without tumor growth, in patients with advanced pancreatic neuroendocrine tumors.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Shelley Suzanne Noland, MD 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (480) 301-8000 | Miss Shelley Suzanne Noland, MD 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (480) 301-8000 |
News Archive
Pfizer Inc. announced that it has settled its litigation against Mylan Inc. and Mylan Pharmaceuticals Inc. relating to Pfizer's patents covering Detrol LA (tolterodine tartrate) extended-release capsules.
Using clinical data collected over the past decade through a U.S. cancer registry, researchers at the University of California, San Diego School of Medicine demonstrated that significant strides have been made in improving the survival of adult patients with low-grade gliomas, a slow-growing yet deadly form of primary brain cancer.
The project, funded by the Ministry of Health, aims to ascertain whether timber workers exposed to the PCPs (pentachlorophenols) are dying earlier, getting cancers more often and suffering more chronic health problems, including fatigue, nausea and neuropsychological dysfunction.
The coronavirus pandemic (COVID-19) has swept across the globe, infecting more than 18 million people. With the rapid spread of the virus, the World Health Organization (WHO) warns that there might never be a "silver bullet" to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Novartis Pharmaceuticals Corporation announced today that a Phase III study of Afinitor (everolimus) tablets plus best supportive care met its primary endpoint, showing the drug significantly extended progression-free survival, or time without tumor growth, in patients with advanced pancreatic neuroendocrine tumors.
› Verified 3 days ago
Sumer Louise Daiza, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 10900 N Scottsdale Rd, 603, Scottsdale, AZ 85254 Phone: 480-585-0011 | |
Dr. Paul Leo Schnur, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 8201 E Del Camino Dr, Scottsdale, AZ 85258 Phone: 480-443-8201 | |
Mrs. Kelly Anne Soares, PA-C Plastic Surgery Medicare: Medicare Enrolled Practice Location: 9819 N 95th St Ste 105, Scottsdale, AZ 85258 Phone: 480-874-2229 | |
Sergey Y Turin, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7301 E 2nd St Ste 202, Scottsdale, AZ 85251 Phone: 480-690-9153 | |
Danielle Anne Thornburg, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Mr. Andrew M Wolin, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3301 N Miller Rd, 140, Scottsdale, AZ 85251 Phone: 480-945-8440 Fax: 480-949-7976 | |
Dr. Erwin Alfonso Kruger, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 |